Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 54 | 319 | 806,431 | 17,970 | 21,337 |
| Gross Profit | 54 | 319 | 806,431 | 17,970 | 21,337 |
| Operating Expenses | 624,353 | 426,958 | 323,685 | 162,753 | 113,304 |
| Operating Income | -624,299 | -426,639 | 482,746 | -144,783 | -91,967 |
| Interest Expense | 4,159 | 4,523 | 4,791 | 5,695 | 6,119 |
| Other Income | 12,025 | 26,428 | 29,933 | 11,644 | 2,232 |
| Pre-tax Income | -616,433 | -404,734 | 507,888 | -138,834 | -95,854 |
| Income Tax | N/A | N/A | 110,333 | -110,265 | N/A |
| Net Income Continuous | -616,433 | -404,734 | 397,555 | -28,569 | -95,854 |
| Net Income Discontinuous | N/A | N/A | N/A | -830 | 3,122 |
| Minority Interests | N/A | N/A | N/A | N/A | -1,325 |
| Net Income | $-616,433 | $-404,734 | $397,555 | $-29,399 | $-91,407 |
| EPS Basic Total Ops | -10.14 | -7.39 | 7.99 | -0.63 | -2.77 |
| EPS Basic Continuous Ops | -10.14 | -7.39 | 7.99 | -0.61 | -2.87 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.02 | 0.10 |
| EPS Diluted Total Ops | -10.14 | -7.39 | 7.69 | -0.63 | -2.77 |
| EPS Diluted Continuous Ops | -10.14 | -7.39 | 7.69 | -0.61 | -2.87 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.02 | 0.10 |
| EPS Diluted Before Non-Recurring Items | -10.14 | -7.39 | 7.69 | -2.95 | -2.63 |
| EBITDA(a) | $-616,180 | $-421,231 | $480,351 | $-141,578 | $-87,553 |